Sara Hildebrand Duffus

MD | Pediatric Endocrinology | Female

Sara Hildebrand Duffus, MD is a Nashville, Tennessee based Pediatric doctor with medical specialization in Pediatric Endocrinology. Sara Hildebrand Duffus is also known as Sara Elise Hildebrand. Current practice location of Sara Hildebrand Duffus is 3841 Green Hills Village Dr Ste 200, Nashville, Tennessee - 37215-2691. She can be contacted on phone at 615-322-3000. Sara Hildebrand Duffus is a sole proprietor of her business.
NPI number (Unique professional ID) for Sara Hildebrand Duffus is 1770979965 which was assigned by NPPES on 14 Apr, 2015 and it was last updated on 12 Apr, 2023. Sara Hildebrand Duffus license number is 2022-03344 for Pediatrics, Pediatric Endocrinology (2080P0205X) in North Carolina.
Sara Hildebrand Duffus provides expert care to infants, children and adolescents who have diseases that result from an abnormality in the endocrine glands (glands which secrete hormones). These diseases include diabetes mellitus, growth failure, unusual size for age, early or late pubertal development, birth defects, the genital region and disorders of the thyroid, the adrenal and pituitary glands.
Complete Profile:
Sara Hildebrand Duffus basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics, Pediatric Endocrinology
Provider Name :Sara Hildebrand Duffus
Other Name :Sara Elise Hildebrand
Credential :MD
Gender :Female
Business Address:
Sara Hildebrand Duffus address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :3841 Green Hills Village Dr Ste 200
Nashville, TN, 37215-2691
United States
Phone Number :615-322-3000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1770979965
NPI Entity Type : Individual
First Enrolment Date : 14 Apr, 2015
Last Updated On : 12 Apr, 2023
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sara Hildebrand Duffus are as mentioned. Primary taxonomy code for Sara Hildebrand Duffus, MD is 2080P0205X (Pediatrics, Pediatric Endocrinology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0205XPediatrics, Pediatric EndocrinologyYes2022-03344NC
2080P0205XPediatrics, Pediatric EndocrinologyNo57642TN
Other Practice Locations:
Practice AddressCity, StatePhone Number
3601 THE VANDERBILT CLINIC,
NASHVILLE, TN, 37232-7220
United States
NASHVILLE, TN615-322-3000
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
Endpoint TypeEndpointAffiliationUseContentAddress
DIRECT
(Direct Messaging Address)
sduffus404892@direct.vumc.org

No affiliationDIRECT
Direct
OTHER
Other
Health Information Service Provider
3601 The Vanderbilt Clinic,
Nashville, TN, 37232-7220
United States
DIRECT
(Direct Messaging Address)
sduffus127300@direct.UNC.nchie.net

No affiliationDIRECT
Direct
OTHER
Other
CDA/CCD/TXT
101 Manning Dr,
Chapel Hill, NC, 27514-4220
United States
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :101 Manning Dr
Chapel Hill, NC, 27514-4220
United States
Phone Number :919-962-2796
Business Location:
Patients can refer following map for directions to Sara Hildebrand Duffus practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.